Bendroflumethiazide

Land: Nieuw-Zeeland

Taal: Engels

Bron: Medsafe (Medicines Safety Authority)

Werkstoffen:

Bendroflumethiazide 2.5mg;  ;  

Beschikbaar vanaf:

Ipca Pharma (NZ) Pty Limited

INN (Algemene Internationale Benaming):

Bendroflumethiazide 2.5 mg

Dosering:

2.5 mg

farmaceutische vorm:

Tablet

Samenstelling:

Active: Bendroflumethiazide 2.5mg     Excipient: Lactose Purified talc Starch Stearic acid

Eenheden in pakket:

Blister pack, PVC/PVDC, 14 tablets

klasse:

Prescription

Prescription-type:

Prescription

Geproduceerd door:

Ipca Laboratories Limited

therapeutische indicaties:

Bendrofluazide is indicated in the treatment of oedema associated with conditions such as: congestive heart failure, nephrotic syndrome and cirrhosis of the liver.

Product samenvatting:

Package - Contents - Shelf Life: Blister pack, PVC/PVDC - 14 tablets - 24 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC - 28 tablets - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE - 500 tablets - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE - 1000 tablets - 24 months from date of manufacture stored at or below 25°C

Autorisatie datum:

2006-06-28